Within the scientific community, innovation and progress go hand-in-hand.  New ideas bring with them better technologies and force scientists and businesspeople alike to ask more questions and think outside the box.  Tech, Drugs and Rock & Roll seeks to foster the growth and development of these fresh concepts by creating a entertaining platform from which innovators can broadcast their ideas and by recognizing and rewarding those individuals who turn their ground-breaking research into advances that benefit mankind.

This year, Tech, Drugs and Rock & Roll will feature a number of significant changes from last year’s event—most notably, the inclusion of elevator pitches from scientists whose technologies will be featured.  Companies such as AcuityBio, which has developed an implant that helps reduce the recurrence of lung cancer, will be able to connect with potential investors and partners in person.  Other technologies that will feature prominently among those being presented at TDRR2011 include Professor Nader Rahimi’s discovery of a novel angiogenic target for potential lung cancer therapies, and RayVio’s development of a durable, low-cost and energy-efficient UV LED which will purify and disinfect water.  TDRR wants to facilitate better connections between its attendees by giving scientists the opportunity to discuss their research with interested parties.

In addition to fostering better connections between scientists and businesspeople, TDRR seeks to highlight and reward individuals with the most compelling achievements.  Last year, Mark Grindstaff won the Innovator of the Year award for his many significant accomplishments including publishing over 60 papers throughout his career and founding three companies: Hyperbranch Medical Technology, AcuityBio and Flex Biomedical.  This year, Boston University’s Provost, Dr. Jean Morrison, will present the award—come to TDRR to find out who will win it!